- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02665572
Outcome of Renal Transplant on a Defunctionalized Bladder
Outcome of Renal Transplant on a Defunctionalized Bladder. A Randomized Controlled Trial
Study Overview
Status
Intervention / Treatment
Detailed Description
Study population:
The study will include patients maintained on hemodialysis for more than 12 months, have oliguria or anuria, reduced bladder capacity, have no history of lower urinary tract dysfunction and have no evidence of urological cause of renal failure. Patients with history of lower urinary tract symptoms before developing renal failure and those with lower urinary tract disease resulting in renal failure will be excluded.
Study design:
It is a randomized controlled trial comparing the outcome of programmed bladder cycling before the time of renal transplantation and direct transplantation without bladder cycling in patients with defunctionalized bladder. Patients, who meet the inclusion criteria, will be randomly allocated into two groups. The first group will undergo renal transplantation on the defunctionalized bladder without bladder recycling. The second group will undergo renal transplantation after bladder recycling.
Measurements:
All patients will be diagnosed by proper history taking, cystoscopy, ascending cystogram and cystometry in order to confirm the diagnosis of reduced bladder capacity and exclude any organic or neurological cause. Bladder recycling will be done by the patient after proper education. It will be started by the instillation of the sterile water in the bladder in amount equal to the estimated bladder capacity. Then the amount will be gradually increased till the patient can withstand filling the bladder with 300 cc of sterile water for 2 hours. Any associated complications will be reported and the time needed to reach the due bladder capacity will be recorded. The procedure of renal transplantation will be carried out according to the hospital protocol and the ureteroneocystostomy will be done by a non-stented Leich Gregoir technique.
Assuming that the bladder will regain its activity and full capacity after 8 weeks of transplantation, all patients will be assessed 3 months after transplantation by the following:
- IPSS questionnaire in order to evaluate the lower urinary tract symptoms.
- Ascending cystogram.
- Cystometry.
- Graft function.
Outcome:
The primary outcome is to evaluate whether bladder recycling is efficient to restore bladder function prior to renal transplantation in terms of IPSS score, and urodynamic evaluation. The secondary outcome is to evaluate the differences in graft and patients outcome between groups.
Power calculation and Statistical analysis:
We hypothesized that at 3 months postoperatively; recipients without bladder training will be non-inferior to those underwent bladder training in terms of cystometric capacity. Based on this, to achieve a difference in mean cystometric capacity of 50 cc in favor of bladder training patients, 16 patients in each group are required to achieve a power of 80% and an α error of 0.05. Statistical power is determined using medcalc version 12.5.0.0 software and all statistical analyses will be performed using IBM version 20 statistical software.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
El Dakahlia
-
Al Manşūrah, El Dakahlia, Egypt, 35516
- Recruiting
- Urology and nephrology center
-
Contact:
- Mohamed H Zahran, Dr
- Phone Number: 0502202638
- Email: zahranmha@yahoo.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- patients maintained on hemodialysis for more than 12 months
- have oliguria or anuria
- reduced bladder capacity
- have no history of lower urinary tract dysfunction and have no evidence of urological cause of renal failure.
Exclusion Criteria:
- Patients with history of lower urinary tract symptoms before developing renal failure and
- those with lower urinary tract disease resulting in renal failure will be excluded
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
NO_INTERVENTION: renal transplant without bladder recycling
the patients allocated to this arm and met inclusion criteria will undergo renal transplant without prior recycling of the bladder
|
|
|
ACTIVE_COMPARATOR: renal transplantation with bladder recycling
the patients allocated in this arm will undergo bladder recycling prior to renal transplantation
|
Bladder recycling will be done by the patient after proper education.
It will be started by the instillation of the sterile water in the bladder in amount equal to the estimated bladder capacity.
Then the amount will be gradually increased till the patient can withstand filling the bladder with 300 cc of sterile water for 2 hours.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
improvement of bladder function after recycling
Time Frame: 3 months
|
to evaluate whether bladder recycling is efficient to restore bladder function prior to renal transplantation by urodynamic evaluation and ascending cystogram to measure the bladder capacity in cm
|
3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
voiding function after renal transplantation
Time Frame: 3 months after renal transplantation
|
|
3 months after renal transplantation
|
|
graft function
Time Frame: 1 year
|
creatinine clearance and estimated GFR by renography ( ml/min/1.73
m2)
|
1 year
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- Zahran MH3182015
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Renal Transplantation Into a Defunctionalized Bladder
-
Prof. Dr. Alice SchmidtUnknownRenal Transplantation | Chronic Hepatitis C-virus InfectionAustria
-
Medicenna Therapeutics, Inc.Merck Sharp & Dohme LLCRecruitingClear Cell Renal Cell Carcinoma | Cervical Cancer | Gastric Cancer | Esophageal Cancer | Ovarian Cancer | Fallopian Tube Cancer | Solid Tumor | Squamous Cell Carcinoma of Head and Neck | Bladder Cancer | Skin Cancer | Triple Negative Breast Cancer | Advanced Solid Tumor | Endometrial Cancer | Primary Peritoneal Cancer and other conditionsUnited States, Australia, Spain, Portugal, Ireland, Canada, Korea, Republic of
Clinical Trials on bladder recycling
-
Gazi UniversityCompleted
-
University of BaghdadCompletedOrthodontic Appliance ComplicationIraq
-
University of VirginiaUniversity of TennesseeCompletedInitial Efficacy of Quit Line | Efficacy of Secondary Reengagement InterventionUnited States
-
Washington University School of MedicineCompleted
-
Catholic University of the Sacred HeartCompletedUterine Cervical NeoplasmsItaly
-
Lancashire Teaching Hospitals NHS Foundation TrustCompletedProstate Cancer | Radiotherapy Side EffectUnited Kingdom
-
Cairo UniversityBedaya HospitalRecruiting
-
Cairo UniversityRecruitingPlacenta Accreta Spectrum | Cesarean HysterectomyEgypt
-
Cairo UniversityBedaya HospitalNot yet recruiting
-
Seoul National University HospitalCompletedNeurogenic Bladder | Detrusor Overactivity | Detrusor UnderactivityKorea, Republic of